iSPOT
International Study to Predict Optimized Treatment Response (iSPOT) - in depression and ADHD
Latest News:
Dr Evian Gordon speaks at Personalized Medicine World Conference. View Video
iSPOT is the largest current Personalized Medicine research study in mental health with the potential to change the way we treat depression and ADHD. At present there is no way to objectively select the correct antidepressant medication to be prescribed in the first instance. Using all the methodology in the picture below, in a standardized manner, iSPOT is assessing which brain and body markers can predict the right medication for the right person at the right time. This will help to personalize treatment in depression and ADHD.
Translational – clinicians will have less trial and error and more objectivity in selecting the right treatment.
Brain Resource’s GOAL: Maximize study recruitment, retention, data quality, IP and scientific publications
Current Status: Over 700 patients have been acquired into the study so far (Total 3000 subjects)
iSPOT Overview (PDF: 500KB)
To email iSPOT Click here http://www.amidepressed.org/
